vs
ASURE SOFTWARE INC（ASUR）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
ASURE SOFTWARE INC的季度营收约是ROCKWELL MEDICAL, INC.的2.0倍（$36.3M vs $18.3M），ROCKWELL MEDICAL, INC.净利率更高（-3.0% vs -14.8%，领先11.8%），ASURE SOFTWARE INC同比增速更快（23.7% vs -25.6%），ASURE SOFTWARE INC自由现金流更多（$5.7M vs $2.2M），过去两年ASURE SOFTWARE INC的营收复合增速更高（11.2% vs -10.1%）
Asure Software是一家软件企业，其前身为Forgent Networks，2007年9月完成品牌更名后，业务逐渐拓展至人力资本管理领域，为客户提供薪资发放、考勤管理、人才管理、人力资源管理、福利管理以及保险相关服务等解决方案。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
ASUR vs RMTI — 直观对比
营收规模更大
ASUR
是对方的2.0倍
$18.3M
营收增速更快
ASUR
高出49.3%
-25.6%
净利率更高
RMTI
高出11.8%
-14.8%
自由现金流更多
ASUR
多$3.4M
$2.2M
两年增速更快
ASUR
近两年复合增速
-10.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $36.3M | $18.3M |
| 净利润 | $-5.4M | $-554.0K |
| 毛利率 | 63.8% | 21.1% |
| 营业利润率 | -9.7% | -2.2% |
| 净利率 | -14.8% | -3.0% |
| 营收同比 | 23.7% | -25.6% |
| 净利润同比 | -37.5% | 26.7% |
| 每股收益（稀释后） | $-0.19 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASURRMTI
| Q4 25 | — | $18.3M | ||
| Q3 25 | $36.3M | $15.9M | ||
| Q2 25 | $30.1M | $16.1M | ||
| Q1 25 | $34.9M | $18.9M | ||
| Q4 24 | — | $24.7M | ||
| Q3 24 | $29.3M | $28.3M | ||
| Q2 24 | $28.0M | $25.8M | ||
| Q1 24 | $31.7M | $22.7M |
净利润ASURRMTI
| Q4 25 | — | $-554.0K | ||
| Q3 25 | $-5.4M | $-1.8M | ||
| Q2 25 | $-6.1M | $-1.5M | ||
| Q1 25 | $-2.4M | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | $-3.9M | $1.7M | ||
| Q2 24 | $-4.4M | $343.0K | ||
| Q1 24 | $-308.0K | $-1.7M |
毛利率ASURRMTI
| Q4 25 | — | 21.1% | ||
| Q3 25 | 63.8% | 14.3% | ||
| Q2 25 | 66.1% | 15.6% | ||
| Q1 25 | 70.6% | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | 67.2% | 22.0% | ||
| Q2 24 | 67.3% | 17.6% | ||
| Q1 24 | 71.4% | 13.5% |
营业利润率ASURRMTI
| Q4 25 | — | -2.2% | ||
| Q3 25 | -9.7% | -9.9% | ||
| Q2 25 | -15.4% | -8.4% | ||
| Q1 25 | -5.8% | -7.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | -12.4% | 6.8% | ||
| Q2 24 | -14.9% | 2.0% | ||
| Q1 24 | -1.4% | -5.8% |
净利率ASURRMTI
| Q4 25 | — | -3.0% | ||
| Q3 25 | -14.8% | -11.0% | ||
| Q2 25 | -20.3% | -9.3% | ||
| Q1 25 | -6.9% | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | -13.3% | 5.9% | ||
| Q2 24 | -15.5% | 1.3% | ||
| Q1 24 | -1.0% | -7.6% |
每股收益（稀释后）ASURRMTI
| Q4 25 | — | $-0.01 | ||
| Q3 25 | $-0.19 | $-0.05 | ||
| Q2 25 | $-0.22 | $-0.05 | ||
| Q1 25 | $-0.09 | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | $-0.15 | $0.04 | ||
| Q2 24 | $-0.17 | $0.01 | ||
| Q1 24 | $-0.01 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $21.5M | $10.7M |
| 总债务越低越好 | $70.4M | — |
| 股东权益账面价值 | $193.1M | $37.0M |
| 总资产 | $447.1M | $57.1M |
| 负债/权益比越低杠杆越低 | 0.36× | — |
8季度趋势，按日历期对齐
现金及短期投资ASURRMTI
| Q4 25 | — | $10.7M | ||
| Q3 25 | $21.5M | $13.6M | ||
| Q2 25 | $66.0M | $12.5M | ||
| Q1 25 | $14.1M | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | $11.2M | $12.3M | ||
| Q2 24 | $20.7M | $11.9M | ||
| Q1 24 | $23.2M | $6.6M |
总债务ASURRMTI
| Q4 25 | — | — | ||
| Q3 25 | $70.4M | — | ||
| Q2 25 | $67.4M | — | ||
| Q1 25 | $14.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $7.5M | — | ||
| Q2 24 | $6.0M | — | ||
| Q1 24 | $5.3M | — |
股东权益ASURRMTI
| Q4 25 | — | $37.0M | ||
| Q3 25 | $193.1M | $37.0M | ||
| Q2 25 | $194.3M | $30.4M | ||
| Q1 25 | $197.7M | $31.5M | ||
| Q4 24 | — | $32.6M | ||
| Q3 24 | $199.2M | $29.1M | ||
| Q2 24 | $195.5M | $23.5M | ||
| Q1 24 | $197.7M | $20.6M |
总资产ASURRMTI
| Q4 25 | — | $57.1M | ||
| Q3 25 | $447.1M | $57.5M | ||
| Q2 25 | $505.6M | $52.6M | ||
| Q1 25 | $498.9M | $54.0M | ||
| Q4 24 | — | $59.2M | ||
| Q3 24 | $428.1M | $57.1M | ||
| Q2 24 | $420.1M | $53.0M | ||
| Q1 24 | $469.3M | $50.7M |
负债/权益比ASURRMTI
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 0.03× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.8M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | $5.7M | $2.2M |
| 自由现金流率自由现金流/营收 | 15.6% | 12.0% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $11.6M | $-1.2M |
8季度趋势，按日历期对齐
经营现金流ASURRMTI
| Q4 25 | — | $2.3M | ||
| Q3 25 | $5.8M | $-1.3M | ||
| Q2 25 | $3.2M | $1.8M | ||
| Q1 25 | $2.0M | $-3.5M | ||
| Q4 24 | — | $865.0K | ||
| Q3 24 | $1.3M | $4.3M | ||
| Q2 24 | $2.2M | $1.4M | ||
| Q1 24 | $-3.9M | $-2.4M |
自由现金流ASURRMTI
| Q4 25 | — | $2.2M | ||
| Q3 25 | $5.7M | $-1.5M | ||
| Q2 25 | $3.0M | $1.7M | ||
| Q1 25 | $1.8M | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | $1.2M | $4.1M | ||
| Q2 24 | $2.1M | $1.2M | ||
| Q1 24 | $-4.2M | $-2.5M |
自由现金流率ASURRMTI
| Q4 25 | — | 12.0% | ||
| Q3 25 | 15.6% | -9.6% | ||
| Q2 25 | 9.8% | 10.5% | ||
| Q1 25 | 5.2% | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | 3.9% | 14.4% | ||
| Q2 24 | 7.5% | 4.5% | ||
| Q1 24 | -13.2% | -11.1% |
资本支出强度ASURRMTI
| Q4 25 | — | 0.5% | ||
| Q3 25 | 0.3% | 1.4% | ||
| Q2 25 | 0.7% | 1.0% | ||
| Q1 25 | 0.6% | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | 0.6% | 0.7% | ||
| Q2 24 | 0.5% | 1.1% | ||
| Q1 24 | 0.8% | 0.6% |
现金转化率ASURRMTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASUR
| Recurring | $31.8M | 88% |
| Lathem Time | $4.6M | 13% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
